Navigation Links
ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
Date:11/6/2007

- New Data Presented at American Heart Association Scientific Sessions 2007

-

ORLANDO, Fla., Nov. 6 /PRNewswire/ -- ARCA Discovery, a privately held biopharmaceutical company, announced today that investigators presented new data analyses on ARCA Discovery's lead product candidate bucindolol, a next-generation beta-blocker and vasodilator for heart failure, atrial fibrillation, and arrhythmia, from the Beta-blocker Evaluation of Survival Trial (BEST) at the American Heart Association's (AHA) Scientific Sessions 2007 Orlando, Florida.

"The data presented today provided us with more evidence supporting the potential of bucindolol as a targeted therapy for the treatment of heart failure," said Michael R. Bristow, M.D., Ph.D., chief science and medical officer of ARCA. "Importantly, we are encouraged by the data demonstrating bucindolol's effect in preventing atrial fibrillation and life threatening ventricular arrhythmia, showing the promise for bucindolol in additional indications. In addition, the BEST trial investigators were able to extend the observation of pharmacogenetic targeting of bucindolol to benefits on cardiovascular hospitalizations, which in effect gives the drug and targeting concept a broader application."

"Effects of Bucindolol on Cardiovascular Mortality and Morbidity Determined by the Beta-1 389 Arg/Gly Receptor Polymorphism Data from a sub-study analysis of the BEST cohort" (Presentation #901) presented by Michel White, M.D. from the Montreal Heart Institute, demonstrated for the first time that in the entire 2,708 patient cohort of BEST, chronic administration of bucindolol results in a significant reduction in cardiovascular hospitalizations, as well as in the previously reported heart failure hospitalizations and cardiovascular mortality. In addition, results were reported from the large (1,040 patient) DNA substudy of BEST, a hypothesis-driven, prospectively-designed study initiated
'/>"/>

SOURCE ARCA Discovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...MOUNTAIN VIEW, Calif., July 24 /PRNewswire-FirstCa... ) announced today that it has initiated,its secon...loxapine).,AZ-004 is an inhalation product candida...ation in patients with schizophrenia or bipolar di...ture and rapid pharmacokinetic,(PK) properties res...
(Date:7/24/2008)...WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Hea...o not tell the whole story. The small scale,preli...line in Human,Reproduction, is based on recollecte...taining soyfoods. "This study is confounded by man... with a great deal of,caution," warned Dr. Tammy H...
(Date:7/24/2008)...Revolutionary thermometer designed to take body te...., July 24 /-- Kidz-Med, In...c. Pink Sheets: ASFX),United States distributor o...r, is pleased to announce the results of a clinica...of the University of Milan, in,Milan, Italy, which...
(Date:7/24/2008)...SOPHIA ANTIPOLIS, France, July 24 /PRNewswire-Firs...nnounced the top-line results from the 52-week,ope...ing the completion of,the 301 phase 3 study for na...ty findings and efficacy was maintained for the on...atients, global assessment scale. In,addition, the...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Diagnostic Imaging New Stock Symbol OTCBB 3A DIIG 3077 1Diagnostic Imaging New Stock Symbol OTCBB 3A DIIG 3077 2Diabetes Growth Disorders Drive Sales of Pediatric Hormone Drugs 11166 1Diabetes Growth Disorders Drive Sales of Pediatric Hormone Drugs 11166 2New study suggests link between environmental toxins and early onset puberty in girls 11163 1New study suggests link between environmental toxins and early onset puberty in girls 11163 2Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 1Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 2Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3074 4
...ropean Hematology,Association (EHA) -, VIENNA, Aus...nomedics, Inc. , a biopharmaceutical company focus...ncer and other serious,diseases, today announced t...Vienna, Austria, showed positive responses in pati...h a new,radioimmunotherapy (RAIT) using epratuzuma...
...007 - Geron,Corporation (Nasdaq:GERN) today announ...g that GRNOPC1, the company,s human,embryonic stem...f,spinal cord injury, evades a direct attack by th...st Ross Okamura at the Federation of,Clinical Immu...s,could mean that patients treated with GRNOPC1 wo...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3
(Date:7/25/2008)...s of Marketing Exclusivity Begins -, CORONA, Cali...aceuticals, Inc. (NYSE: WPI ), a leading specialt... subsidiary has commenced commercial,shipment of i... in the 40mg,strength from its Davie, Florida manu..., Watson has 180 days of marketing exclusivity for...
(Date:7/25/2008)...ion Executive, Robert J. Reilly, Joins Aethon Team...,( http://www.aethon.com ), the leading developer ...tics, today announced that Robert J. Reilly has,jo... Financial Officer., Reilly, who was most recentl...orporation,s Specialty Pharmacy Division, brings m...
(Date:7/25/2008)...ewswire/ -- The Elekta Family of Companies will,sh...ions at the 2008,American Association of Physicist... how the joint forces of Elekta, IMPAC and CMS are...g and delivery solutions that,streamline the treat...ients, as well as enhance clinician efficiency., ...
(Date:7/25/2008)...y 25 /PRNewswire/ -- AutoGenomics, Inc. today,anno...n Form S-1 with the,Securities and Exchange Commis...ing of shares of its common stock. The number of s...are expected to be offered by,AutoGenomics, Inc., ... been,determined., J.P. Morgan Securities Inc. is...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ng 20 paintings by renowned masters like M.F. Husa...ment a similar theme to be etched out at Sunday's ...Week. "There are different kinds of desire in a h... fulfilled, some only dream about it. But it's som...
...n people as young as 16 whereas the phenomenon onc... says. "Nobody can escape stress in modern day li...cts like a male hormone and causes the thinning of... Shah said. "Initially, we used to see this begin...
...Saturday in Burhanpur district of Madhya Pradesh i...Maharashtra testing positive for the deadly bird f...ation will also be paid to 323 affected poultry ow...cted," said Rajesh Rajora, commissioner of the sta...
...University are pumping for a controversial theory,...e forced// into "dark states" where they can be ea... idea appears to contravene some of the most accep...y, not long ago dismissed as impossible by much of...
Other Medicine News:Health News:India Fashion Week Reveals - 'The Story Of Desire' 2Health News:Stress Can Cause Hair loss at 16 2Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 2Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 3
2-ply material consisting of polyethylene film inner layer and non-woven outer layers.
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass.
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room.
Medicine Products: